Your browser is no longer supported. Please, upgrade your browser.
Settings
BVXV BiondVax Pharmaceuticals Ltd. daily Stock Chart
BVXV [NASD]
BiondVax Pharmaceuticals Ltd.
Index- P/E- EPS (ttm)-2.99 Insider Own41.28% Shs Outstand10.84M Perf Week8.25%
Market Cap456.91M Forward P/E- EPS next Y-0.06 Insider Trans0.00% Shs Float6.44M Perf Month6.35%
Income-31.60M PEG- EPS next Q-0.01 Inst Own3.80% Short Float0.28% Perf Quarter65.66%
Sales- P/S- EPS this Y0.40% Inst Trans9.91% Short Ratio0.16 Perf Half Y484.40%
Book/sh-1.67 P/B- EPS next Y0.00% ROA- Target Price- Perf Year646.38%
Cash/sh1.02 P/C40.43 EPS next 5Y- ROE207.10% 52W Range5.20 - 62.00 Perf YTD343.49%
Dividend- P/FCF- EPS past 5Y-19.00% ROI- 52W High-33.55% Beta2.19
Dividend %- Quick Ratio6.50 Sales past 5Y- Gross Margin- 52W Low692.29% ATR3.22
Employees17 Current Ratio6.50 Sales Q/Q- Oper. Margin- RSI (14)54.20 Volatility7.11% 8.88%
OptionableNo Debt/Eq- EPS Q/Q46.60% Profit Margin- Rel Volume0.29 Prev Close42.41
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume109.77K Price41.20
Recom- SMA205.01% SMA505.10% SMA200112.66% Volume31,422 Change-2.85%
Aug-31-20 06:15AM  
Aug-20-20 04:01PM  
Aug-13-20 04:01PM  
Jul-01-20 06:00AM  
Jun-30-20 04:01PM  
Jun-16-20 08:57AM  
Jun-12-20 08:00AM  
Jun-10-20 07:00AM  
May-20-20 06:30AM  
May-09-20 08:47AM  
May-04-20 06:30AM  
Mar-24-20 04:01PM  
Mar-19-20 07:15AM  
Feb-05-20 01:00PM  
Jan-16-20 03:05PM  
Dec-04-19 08:25AM  
Nov-26-19 07:00AM  
Nov-18-19 07:15AM  
Nov-11-19 08:14AM  
Oct-07-19 09:15AM  
Aug-28-19 07:45AM  
Aug-01-19 10:00AM  
Jul-16-19 07:30AM  
Jul-08-19 05:45AM  
Jun-26-19 10:51AM  
Jun-25-19 09:37AM  
Jun-18-19 06:30AM  
Jun-12-19 03:30PM  
Jun-10-19 08:18AM  
May-30-19 07:10AM  
May-13-19 07:00AM  
Apr-30-19 04:01PM  
Apr-22-19 08:10AM  
Apr-17-19 01:00PM  
Apr-15-19 07:50AM  
Mar-28-19 07:30AM  
Mar-21-19 07:00AM  
Nov-28-18 07:40AM  
Nov-26-18 07:00AM  
Nov-20-18 11:00AM  
Nov-19-18 07:00AM  
Nov-13-18 04:01PM  
Oct-24-18 07:00AM  
Oct-22-18 08:00AM  
Oct-17-18 08:15AM  
Sep-05-18 09:30AM  
Sep-04-18 06:15AM  
Aug-22-18 07:00AM  
Aug-20-18 07:50AM  
07:00AM  
Aug-14-18 06:00AM  
Aug-08-18 08:30AM  
Jun-28-18 07:00AM  
Jun-19-18 09:00AM  
Jun-05-18 07:45AM  
Jun-01-18 10:30AM  
May-29-18 07:00AM  
May-07-18 09:45AM  
Apr-30-18 04:05PM  
Apr-13-18 07:20AM  
Apr-12-18 06:30AM  
Apr-11-18 07:45AM  
Apr-09-18 08:15AM  
Mar-15-18 08:25AM  
Mar-13-18 09:00AM  
Feb-08-18 08:30AM  
Jan-02-18 09:00AM  
Dec-27-17 09:00AM  
Dec-12-17 12:00PM  
Dec-11-17 07:30AM  
Dec-05-17 09:00AM  
Nov-28-17 09:00AM  
Nov-20-17 09:00AM  
Sep-20-17 01:00PM  
Sep-18-17 11:35AM  
Sep-13-17 08:25PM  
04:55PM  
11:07AM  
Sep-12-17 07:15AM  
Aug-31-17 07:30AM  
07:30AM  
Aug-14-17 08:00AM  
Aug-01-17 01:00PM  
Jul-20-17 06:30AM  
Jul-18-17 07:30AM  
Jul-06-17 01:00PM  
Jun-28-17 04:01PM  
Jun-19-17 07:00AM  
Jun-12-17 08:15AM  
Jun-02-17 01:00PM  
May-30-17 07:00AM  
May-08-17 03:00PM  
Apr-28-17 08:00AM  
Mar-30-17 11:59AM  
02:00AM  
Mar-13-17 09:30AM  
Jan-20-17 11:30AM  
Jan-12-17 07:00AM  
Jan-02-17 03:00AM  
Dec-01-16 11:00AM  
BiondVax Pharmaceuticals Ltd., a clinical stage biopharmaceutical company, focuses on developing and commercializing immunomodulation therapies for infectious diseases primarily in Israel. Its product candidate is M-001, a synthetic peptide-based protein, which is in Phase III clinical trials for treatment of seasonal and pandemic strains of the influenza virus. The company was founded in 2003 and is headquartered in Jerusalem, Israel.